Efficacy and Safety of Escitalopram in Patients With Social Anxiety Disorder; Open-Label, One Arm Postmarketing Study in Russia.
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2012
At a glance
- Drugs Escitalopram (Primary)
- Indications Social phobia
- Focus Therapeutic Use
- Sponsors Lundbeck A/S
- 01 Apr 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 01 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.